Dyadic International, Inc. (DYAI)
Dyadic International, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Dyadic International, Inc. (DYAI) is a Biotechnology company based in US with a market capitalization of $53.6M. Revenue declined 64.7% year-over-year and free cash flow was negative at -$5.7M. This page tracks DYAI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 6 employees · IPO Jan 16, 2008
Valuation
Valuation & price
$0.72as of May 17, 2026· -44.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
43.46
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$53.6M
Market cap
-64.7%
Revenue growth (YoY)
-88.3%
Gross margin
-$5.7M
Free cash flow (USD)
-$2.3M
Net debt
Net cash position
11.3%
Share dilution
0/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
2
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 24, 2026Filing
Insider Sell $125KFrancisco Trust under agreement dated February 28, 1996 · 10% Owner · $125K
- 8-K eventJul 24, 2026Filing
Compliance Regained
- Insider sellJul 6, 2026Filing
Insider Sell $344KFrancisco Trust under agreement dated February 28, 1996 · 10% Owner · $343.8K
- 8-K eventJun 22, 2026Filing
Annual Meeting Results
- 8-K eventJun 18, 2026Filing
Delisting Notice
- 8-K eventJun 15, 2026Filing
Press Release Issued
- 8-K eventMay 28, 2026Filing
Collaboration Announcement
- Quarterly reportMay 13, 2026Filing
10-Q Filed
- 8-K eventMay 13, 2026Filing
Earnings Release
- Annual reportApr 30, 2026Filing
10-K Filed
Questions
Frequently asked questions
What is Dyadic International, Inc.'s market cap?
Dyadic International, Inc. (DYAI) has a market capitalization of $53.6M.
What is DYAI's P/E ratio?
A meaningful P/E ratio is not available for DYAI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is DYAI's price-to-book (P/B) ratio?
DYAI trades at 43.46 times book value per share.
Are insiders buying DYAI stock?
SEC Form 4 filings show no open-market insider buys at Dyadic International, Inc. in the last 90 days (2 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.